Eris Lifesciences Limited (NSEI:ERIS) agreed to acquire Portfolio of Nine Dermatology Brands of Dr Reddy's Laboratories for INR 2.8 billion on March 16, 2023. Consideration will be paid in cash. Portfolio reported turnover of INR 616 million for FY 21-22. The transaction is expected to complete on March 31, 2023. As on March 21, 2023, Dr Reddy's Laboratories so far the completion has been advanced and is now targeted to happen on or about March 24, 2023 instead of the previously targeted date of March 31, 2023. Kalpana Unadkat, Aman Anand and Ahaan Dar of Khaitan & Co. acted as legal advisor to Eris Lifesciences Limited (NSEI:ERIS).

Eris Lifesciences Limited (NSEI:ERIS) completed the acquisition of Portfolio of Nine Dermatology Brands of Dr Reddy's Laboratories on March 24, 2023. Nitin Lath, Hetal Vora and Dhruvin Shah of Stifel Financial Corp. acted as financial advisor to Dr Reddy's Laboratories in the transaction. Kalpana Unadkat of Khaitan & Co. acted as legal advisor to Eris Lifesciences Limited (NSEI:ERIS).